Adenocarcinoma_of_the_pancreas:_a_multimodality_approach--a_single_surgeon's_experience_(1979-1988)._A_retrospective_review_of_a_single_surgeon's_experience_with_adenocarcinoma_of_the_pancreas_was_performed._One_hundred-one_patients_were_treated_over_a_10-year_period_from_1979_to_1988._Seven_patients_underwent_potentially_curative_resections_and_28_patients_presented_with_metastatic_(stage_IV)_disease._Sixty-four_patients_had_locally_advanced_and_unresectable_primary_lesions._A_total_of_51_patients_received_I-125_seed_implantation._There_was_no_statistically_significant_difference_in_morbidity_(33%_vs._30%)_or_mortality_(6%_vs._8%)_between_patients_receiving_I-125_implantation_and_those_undergoing_palliative_surgical_procedures_without_implantation._Operative_mortality_was_highest_in_patients_presenting_with_stage_IV_lesions_(11%)._In_those_patients_with_locally_advanced_and_unresectable_carcinomas,_there_was_a_nonsignificant_increase_in_survival_(12.8_mo_vs._10.7_mo)_in_those_receiving_intraoperative_I-125_implants_when_compared_to_those_who_did_not_when_both_groups_received_postoperative_adjuvant_chemotherapy_and_external_beam_radiotherapy._Based_on_these_encouraging_results,_it_is_concluded_that_I-125_implantation_can_be_performed_safely_and_shows_a_trend_toward_improving_long-term_survivorship_in_patients_with_locally_advanced_pancreatic_carcinoma_when_used_in_conjunction_with_chemotherapy_and_external_beam_radiation.